These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


309 related items for PubMed ID: 15065873

  • 1. Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones.
    Wang Q, Dubé D, Friesen RW, LeRiche TG, Bateman KP, Trimble L, Sanghara J, Pollex R, Ramachandran C, Gresser MJ, Huang Z.
    Biochemistry; 2004 Apr 13; 43(14):4294-303. PubMed ID: 15065873
    [Abstract] [Full Text] [Related]

  • 2. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
    Takakura K, Beckman JS, MacMillan-Crow LA, Crow JP.
    Arch Biochem Biophys; 1999 Sep 15; 369(2):197-207. PubMed ID: 10486138
    [Abstract] [Full Text] [Related]

  • 3. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
    Denu JM, Tanner KG.
    Biochemistry; 1998 Apr 21; 37(16):5633-42. PubMed ID: 9548949
    [Abstract] [Full Text] [Related]

  • 4. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B.
    van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H.
    Nature; 2003 Jun 12; 423(6941):773-7. PubMed ID: 12802339
    [Abstract] [Full Text] [Related]

  • 5. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
    Glover NR, Tracey AS.
    Biochem Cell Biol; 2000 Jun 12; 78(1):39-50. PubMed ID: 10735562
    [Abstract] [Full Text] [Related]

  • 6. Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells.
    Lou YW, Chen YY, Hsu SF, Chen RK, Lee CL, Khoo KH, Tonks NK, Meng TC.
    FEBS J; 2008 Jan 12; 275(1):69-88. PubMed ID: 18067579
    [Abstract] [Full Text] [Related]

  • 7. Singlet oxygen inactivates protein tyrosine phosphatase-1B by oxidation of the active site cysteine.
    von Montfort C, Sharov VS, Metzger S, Schöneich C, Sies H, Klotz LO.
    Biol Chem; 2006 Jan 12; 387(10-11):1399-404. PubMed ID: 17081112
    [Abstract] [Full Text] [Related]

  • 8. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
    Skorey KI, Kennedy BP, Friesen RW, Ramachandran C.
    Anal Biochem; 2001 Apr 15; 291(2):269-78. PubMed ID: 11401301
    [Abstract] [Full Text] [Related]

  • 9. Redox regulation of MAP kinase phosphatase 3.
    Seth D, Rudolph J.
    Biochemistry; 2006 Jul 18; 45(28):8476-87. PubMed ID: 16834321
    [Abstract] [Full Text] [Related]

  • 10. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M, Zhao L, Aubry I, Schmidt-Arras D, Böhmer FD, Li CJ, Tremblay ML.
    Chembiochem; 2007 Jan 22; 8(2):179-86. PubMed ID: 17191286
    [Abstract] [Full Text] [Related]

  • 11. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate.
    Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D.
    Nature; 2003 Jun 12; 423(6941):769-73. PubMed ID: 12802338
    [Abstract] [Full Text] [Related]

  • 12. A chemical model for redox regulation of protein tyrosine phosphatase 1B (PTP1B) activity.
    Sivaramakrishnan S, Keerthi K, Gates KS.
    J Am Chem Soc; 2005 Aug 10; 127(31):10830-1. PubMed ID: 16076179
    [Abstract] [Full Text] [Related]

  • 13. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
    Yang J, Groen A, Lemeer S, Jans A, Slijper M, Roe SM, den Hertog J, Barford D.
    Biochemistry; 2007 Jan 23; 46(3):709-19. PubMed ID: 17223692
    [Abstract] [Full Text] [Related]

  • 14. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines.
    Chen CY, Willard D, Rudolph J.
    Biochemistry; 2009 Feb 17; 48(6):1399-409. PubMed ID: 19166311
    [Abstract] [Full Text] [Related]

  • 15. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction.
    Sohn J, Rudolph J.
    Biochemistry; 2003 Sep 02; 42(34):10060-70. PubMed ID: 12939134
    [Abstract] [Full Text] [Related]

  • 16. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
    Drake PG, Peters GH, Andersen HS, Hendriks W, Møller NP.
    Biochem J; 2003 Jul 15; 373(Pt 2):393-401. PubMed ID: 12697028
    [Abstract] [Full Text] [Related]

  • 17. Effects of metal ions on the activity of protein tyrosine phosphatase VHR: highly potent and reversible oxidative inactivation by Cu2+ ion.
    Kim JH, Cho H, Ryu SE, Choi MU.
    Arch Biochem Biophys; 2000 Oct 01; 382(1):72-80. PubMed ID: 11051099
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B).
    Tjernberg A, Hallén D, Schultz J, James S, Benkestock K, Byström S, Weigelt J.
    Bioorg Med Chem Lett; 2004 Feb 23; 14(4):891-5. PubMed ID: 15012988
    [Abstract] [Full Text] [Related]

  • 19. Redox regulation of protein tyrosine phosphatase 1B (PTP1B): a biomimetic study on the unexpected formation of a sulfenyl amide intermediate.
    Sarma BK, Mugesh G.
    J Am Chem Soc; 2007 Jul 18; 129(28):8872-81. PubMed ID: 17585764
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.